Fig. 2From: Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapseUMAP representation and identification of cellular subsets by ADT-labeling of the integrated CITE-Seq from a CLL patient during ibrutinib treatmentBack to article page